Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Department of General Surgery, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China.
Int J Surg. 2020 Jul;79:17-28. doi: 10.1016/j.ijsu.2020.03.052. Epub 2020 Mar 30.
Repeat laparoscopic hepatectomy (LRH) offers an option for recurrent tumors in liver remnants following an initial liver resection of recurrent hepatocellular carcinoma (HCC), colorectal liver metastasis (CRLM) and cholangiocellular carcinoma (CCC), showing advantages in some outcomes. The objective of the study was to evaluate the feasibility, safety, and potential benefits of LRH in comparison with repeat open hepatectomy (ORH) for recurrent liver cancer.
A systematic review was performed in compliance with the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) and AMSTAR (Assessing the methodological quality of systematic reviews) guidelines. We performed a systematic search of PubMed, Embase, Cochrane Library, and Web of Science to identify studies that compared LRH with ORH from inception to September 30, 2019. Outcomes of interest included operation time, intraoperative estimated blood loss, length of hospital stay, complication rate, transfusion and R0 resection rate. The protocol was registered with the PROSPERO register of systematic reviews.
10 retrospective observational studies were suitable for this analysis, involving 767 patients with 334 undergoing LRH (43.5%) and 433 undergoing ORH (56.5%). Compared with ORH, LRH had less intraoperative blood loss (SMD = -1.03; 95% CI: 1.48-0.59, P < 0.001), less overall postoperative complications (OR = 0.40; 95% CI: 0.16-0.99, P = 0.048), less major complications (OR = 0.31, 95% CI: 0.15-0.62, P = 0.001), shorter hospital stay (SMD = -0.98; 95% CI: 1.41-0.54, P < 0.001) and higher R0 resection rate (OR = 2.30, 95% CI: 1.39-3.81, P = 0.001). It was comparable in operation time (WMD = -7.66; 95% CI: 52.50-37.19, P = 0.738), transfusion rate (OR = 0.33; 95% CI:0.11-1.05, P = 0.060), and mortality (OR = 0.76; 95% CI: 0.27-2.18, P = 0.615) between LRH and ORH.
Our results indicate that LRH is a safe and effective technique. Benefits, especially less intra-operative blood loss, less complications rate, shorter hospital stay and higher R0 resection, might be offered in the laparoscopic approach.
对于初始肝切除术后复发的肝癌患者,重复腹腔镜肝切除术(LRH)为肝残部的复发性肿瘤提供了一种选择,对于复发性肝细胞癌(HCC)、结直肠癌肝转移(CRLM)和胆管细胞癌(CCC),LRH 在某些结果方面具有优势。本研究的目的是评估 LRH 与重复开腹肝切除术(ORH)相比在治疗复发性肝癌方面的可行性、安全性和潜在益处。
本研究按照 PRISMA(系统评价和荟萃分析的首选报告项目)和 AMSTAR(系统评价方法学质量评估)指南进行系统评价。我们对 PubMed、Embase、Cochrane 图书馆和 Web of Science 进行了系统检索,以确定自 1970 年 1 月至 2019 年 9 月 30 日期间比较 LRH 与 ORH 的研究。感兴趣的结果包括手术时间、术中估计出血量、住院时间、并发症发生率、输血和 R0 切除率。该方案已在系统评价的 PROSPERO 注册处注册。
10 项回顾性观察性研究适合本分析,共纳入 767 例患者,其中 334 例接受 LRH(43.5%),433 例接受 ORH(56.5%)。与 ORH 相比,LRH 术中出血量更少(SMD=-1.03;95%CI:1.48-0.59,P<0.001),总术后并发症更少(OR=0.40;95%CI:0.16-0.99,P=0.048),主要并发症更少(OR=0.31,95%CI:0.15-0.62,P=0.001),住院时间更短(SMD=-0.98;95%CI:1.41-0.54,P<0.001),R0 切除率更高(OR=2.30,95%CI:1.39-3.81,P=0.001)。LRH 与 ORH 在手术时间(WMD=-7.66;95%CI:52.50-37.19,P=0.738)、输血率(OR=0.33;95%CI:0.11-1.05,P=0.060)和死亡率(OR=0.76;95%CI:0.27-2.18,P=0.615)方面差异无统计学意义。
我们的结果表明 LRH 是一种安全有效的技术。与开腹手术相比,LRH 可能具有更少的术中出血、更低的并发症发生率、更短的住院时间和更高的 R0 切除率等优势。